Bradsher Neal C
SEC insider (Form 3/4/5 filer). CIK 0001278388. Director & 10% Owner at Lineage Cell Therapeutics, Inc. (LCTX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in NEW YORK, NY.
Companies Bradsher Neal C has filed insider reports for
- Lineage Cell Therapeutics, Inc. (LCTX): Director, 10% Owner
- STAAR SURGICAL CO (STAA): Director, 10% Owner
Bradsher Neal C
CIK: 0001278388
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 1, 2026LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectOPTION TO PURCHASE COMMON SHARES
125K shares- - Jun 18, 2026STAA
STAAR SURGICAL CO
AwardDirectOPTION TO PURCHASE COMMON STOCK
11.1K shares- - Mar 6, 2026STAA
STAAR SURGICAL CO
AwardDirectOPTION TO PURCHASE COMMON STOCK
7.5K shares- - Jul 1, 2025LCTX
Lineage Cell Therapeutics, Inc.
AwardDirectOPTION TO PURCHASE COMMON SHARES
75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  LCTX Lineage Cell Therapeutics, Inc. | Award OPTION TO PURCHASE COMMON SHARES | 125,000 | - | - | Direct |
| Jun 18, 2026 |  STAA STAAR SURGICAL CO | Award OPTION TO PURCHASE COMMON STOCK | 11,145 | - | - | Direct |
| Mar 6, 2026 | STAA STAAR SURGICAL CO | Award OPTION TO PURCHASE COMMON STOCK | 7,524 | - | - | Direct |
| Jul 1, 2025 | LCTX Lineage Cell Therapeutics, Inc. | Award OPTION TO PURCHASE COMMON SHARES | 75,000 | - | - | Direct |
1-4 of 4 transactions